Trial Profile
Retrospective chart review of patients with fistulizing Crohn's Disease treated with Ustekinumab , a Real-life data study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Jan 2018
Price :
$35
*
At a glance
- Drugs Ustekinumab (Primary) ; Ustekinumab (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- 18 Jan 2018 New trial record